Mr. Lovendale’s representative clients and transactions include:
Public Offerings
- argenx SE in its $115 million initial U.S. public offering and $266 million public follow-on offering
- BeiGene, Ltd. in its $182 million initial public offering and $200 million, $201 million and $800 million follow-on public offerings
- ConforMIS, Inc. in its $23 million follow-on offering
- Galapagos NV in its $275 million initial U.S. public offering and $371 million follow-on offering
- Intellia Therapeutics, Inc. in its $150 million follow-on offering
Mergers and Acquisitions
- Charlesbank Capital Partners, LLC, regarding intellectual property matters, in its respective investments in, or purchases of, a variety of technology and other companies
- Continuum Managed Services, LLC, regarding intellectual property matters, on its sale to an entity controlled by Thoma Bravo, LLC from Summit Partners
- EPR Properties, regarding intellectual property matters, in its acquisition of CNL Lifestyle Properties together with a co-buyer, Och-Ziff Real Estate
- Semma Therapeutics, Inc. in its acquisition of CytoSolv, Inc., a developer of encapsulating cell technology
Private Financings
- Naurex, Inc. in its $80 million Series C financing
- RaNA Therapeutics, LLC in its $55 million Series B financing
- Semma Therapeutics, Inc. in its $44 million Series A financing and $114 million Series B financing
Prior to joining Goodwin, Mr. Lovendale served as a legal intern at The Law Office of Zick Rubin (now Rubin & Ulrich LLC)—a firm specializing in publishing law, copyright, trademark and intellectual property issues in higher education—and Community Action Program Legal Services, Inc. (CAPLAW).